Whatever the background of STING’s (Stockholm Innovation and Growth) innovation ideas, they all have the potential to become successful technology-based export companies. Not surprisingly, medical technology companies feature prominently in the STING portfolio.

Cutting-edge support in medical technology

– We are based all over in of Stockholm, in Kista right in the middle of Sweden’s foremost IT-cluster, at the KTH campus and also on the Flemingsberg Campus, says Gösta Sjöholm, business coach at STING. The cluster’s competencies and networks are of great value to the companies we assist.

The facilities at Flemingsberg, south of Stockholm, were inaugurated recently. Here Karolinska Institutet, KTH and Södertörns University already operate educational and research labs. This combination of actors is expected to drive medical technology innovations, adding to STING’s well-developed track-record in this area.

Advice and long-term investment offering

Like Karolinska Institutet’s innovation support, STING provides a close combination of advice and investment. Assistance in finding investors is a crucial part of the offer. STING-managed STING Capital offers early-phase investment, and companies in which investment is made are normally within the STING business development programs, even if the fund can invest in other companies too.  STING Capital invests in the very early stage and actively looks for a second investor to take on after the seed stage.

One company that got off to a great start under STING’s wing is Obstecare.